Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer (Q45149311)
Jump to navigation
Jump to search
scientific article published in December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer |
scientific article published in December 2004 |
Statements
1 reference
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer (English)
1 reference
Jean-Yves Douillard
1 reference
Christian Peschel
1 reference
Frances Shepherd
1 reference
Luis Paz-Ares
1 reference
Andrew Arnold
1 reference
Mary Davis
1 reference
Maurizio Tonato
1 reference
Michael Smylie
1 reference
Dongsheng Tu
1 reference
Maurizio Voi
1 reference
Jeffrey Humphrey
1 reference
Jon Ottaway
1 reference
Katherine Young
1 reference
Anne Van Vreckem
1 reference
Lesley Seymour
1 reference
1 December 2004
1 reference
1 reference
46
1 reference
3
1 reference
361-368
1 reference
Identifiers
1 reference
1 reference